Literature DB >> 11721760

An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking.

P Pare1, S Ferrazzi, W G Thompson, E J Irvine, L Rance.   

Abstract

OBJECTIVES: The prevalence of functional constipation is highly variable among epidemiological surveys and may relate to the definitions applied. We estimated the population prevalence of self-reported, Rome I-defined, and Rome II-defined constipation in Canada and determined the variables that best predicted health care seeking.
METHODS: A research firm was employed to conduct a random digit dial national survey, inviting household members at least 18 yr of age to participate in a study assessing personal health issues. The sample was stratified to ensure that each region of Canada was represented. Data collection involved three stages: 1) recruitment of participants by phone, 2) mailing of the questionnaire, and 3) data retrieval through a follow-up phone call. The Rome II questionnaire was used to derive the prevalence of functional constipation using both Rome I and Rome II criteria.
RESULTS: Of the 1149 participants, 27.2% self-reported constipation within the past 3 months, and 16.7% and 14.9% had functional constipation according to Rome I and II, criteria, respectively. For all three definitions, the rate for women was close to twice that for men. Approximately 34% of those with self-reported constipation had visited a physician for it, versus 26.3% of Rome II subjects. In a regression model, subjects self-reporting in the past 3 months were more likely to have seen a doctor for their constipation (odds ratio 2.47, p < 0.01) and significantly more women than men (35.6% vs 19.5%, p < 0.05).
CONCLUSIONS: Functional constipation and related health care seeking are common in the Canadian population and are strongly determined by the definition used. The Rome II criteria for this disorder seem to be satisfactory, but modifications may be considered to allow for constipated subjects taking laxatives and to increase the number of qualifying symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11721760     DOI: 10.1111/j.1572-0241.2001.05259.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  121 in total

1.  Clinical features of constipation in general practice in Italy.

Authors:  Carmelo Cottone; Cesare Tosetti; Giuseppe Disclafani; Enzo Ubaldi; Rosanna Cogliandro; Vincenzo Stanghellini
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

Review 2.  Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation.

Authors:  Pierre Paré; Richard N Fedorak
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

Review 3.  Lubiprostone in constipation: clinical evidence and place in therapy.

Authors:  Nicholas Wilson; Ron Schey
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

4.  Factors associated with persistent and nonpersistent chronic constipation, over 20 years.

Authors:  Rok Seon Choung; G Richard Locke; Enrique Rey; Cathy D Schleck; Charles Baum; Alan R Zinsmeister; Nicholas J Talley
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

5.  Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort study.

Authors:  Rok Seon Choung; Nilay D Shah; Denesh Chitkara; Megan E Branda; Miranda A Van Tilburg; William E Whitehead; Slavica K Katusic; G Richard Locke; Nicholas J Talley
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-01       Impact factor: 2.839

6.  Longitudinal direct medical costs associated with constipation in women.

Authors:  R S Choung; M E Branda; D Chitkara; N D Shah; S K Katusic; G R Locke; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2010-11-22       Impact factor: 8.171

Review 7.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

8.  Sacral nerve stimulation for constipation: do we still miss something? Role of psychological evaluation.

Authors:  Alfonso Carriero; Jacopo Martellucci; Pasquale Talento; Carlo Andrea Ferrari
Journal:  Int J Colorectal Dis       Date:  2010-02-17       Impact factor: 2.571

Review 9.  Dyssynergic defecation and biofeedback therapy.

Authors:  Satish S C Rao
Journal:  Gastroenterol Clin North Am       Date:  2008-09       Impact factor: 3.806

10.  Short-term results after STARR versus internal Delorme for obstructed defecation: a non-randomized prospective study.

Authors:  N L Ohazuruike; J Martellucci; C Menconi; S Panicucci; G Toniolo; G Naldini
Journal:  Updates Surg       Date:  2014-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.